We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Snake charmer needed to soothe this debate

Phil Gunby
JAMA. 1980;244(22):2496. doi:10.1001/jama.1980.03310220006003.
Text Size: A A A
Published online


More controversy than ever surrounds the already controversial use of snake venom for treatment of multiple sclerosis.

  • The Food and Drug Administration and a Florida serpentarium are in federal court over manufacture and distribution of the venom product.

  • The National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) has turned down a grant request from the National Multiple Sclerosis Society to study the venom.

  • The National Center for Toxicological Research, located at the Army's Pine Bluff Arsenal, Jefferson, Ark, has begun animal tests with a small amount of the material, obtained from the FDA's Bureau of Biologics.

The FDA initially asked the Florida serpentarium owner to stop selling the snake venom product to multiple sclerosis and arthritis patients for the time being. It then offered "to cooperate with anyone interested in testing the venom, marketed as PRO-ven." When the serpentarium owner apparently decided not to go along with the


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.